Dual [(68)Ga]DOTATATE and [(18)F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score.

Auteurs : Chan DL, Hayes AR, Karfis I, Conner A, Furtado OMahony L, Mileva M, Bernard E, Roach P, Marin G, Pavlakis N, Schembri G, Gnanasegaran G, Marin C, Vanderlinden B, Navalkissoor S, Caplin ME, Flamen P, Toumpanakis C, Bailey DL
Jaar : 2022
Journal : Br J Cancer
Volume : 128
Pagina's : 549-55

Correction to: Combined quality and dose-volume histograms for assessing the predictive value of ^99mTc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer.

Auteurs : Levillain H, Burghelea M, Derijckere ID, Guiot T, Gulyban A, Vanderlinden B, Vouche M, Flamen P, Reynaert N
Jaar : 2021
Journal : EJNMMI Phys
Volume : 8
Pagina's : 9

Combined quality and dose-volume histograms for assessing the predictive value of ^99mTc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer.

Auteurs : Levillain H, Burghelea M, Derijckere ID, Guiot T, Gulyban A, Vanderlinden B, Vouche M, Flamen P, Reynaert N
Jaar : 2020
Journal : EJNMMI Phys
Volume : 7
Pagina's : 75

Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter study.

Auteurs : Levillain H, Duran Derijckere I, Ameye L, Guiot T, Braat A, Meyer C, Vanderlinden B, Reynaert N, Hendlisz A, Lam M, Deroose CM, Ahmadzadehfar H, Flamen P
Jaar : 2019
Journal : Eur J Nucl Med Mol Imaging
Volume : 46
Pagina's : 2270-2279

A dosimetry procedure for organs-at-risk in ¹⁷⁷Lu peptide receptor radionuclide therapy of patients with neuroendocrine tumours.

Auteurs : Marin G, Vanderlinden B, Karfis I, Guiot T, Wimana Z, Reynaert N, Vandenberghe S, Flamen P
Jaar : 2018
Journal : Phys Med
Volume : 56
Pagina's : 41-49

Selective internal radiation therapy (SIRT) before partial hepatectomy or radiofrequency destruction for treatment of hepatocellular carcinoma in cirrhotic patients: a feasibility and safety pilot study.

Auteurs : Lemaire M, Lucidi V, Bouazza F, Katsanos G, Vanderlinden B, Levillain H, Delatte P, Garcia CA, Vouche M, Gomez Galdon M, Demetter P, Deleporte A, Hendlisz A, Flamen P, Donckier V
Jaar : 2018
Journal : HPB (Oxford)
Volume : 20(7)
Pagina's : 641-648

90Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer.

Auteurs : Levillain H, Duran Derijckere I, Marin G, Guiot T, Vouche M, Reynaert N, Hendlisz A, Vanderlinden B, Flamen P
Jaar : 2018
Journal : EJNMMI Res
Volume : 8
Pagina's : 60

N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by 89Zr-Trastuzumab and 18F-FDG PET imaging.

Auteurs : Wimana Z, Gebhart G, Guiot T, Vanderlinden B, Larsimont D, Doumont G, Van Simaeys G, Goldman S, Flamen P, Ghanem G
Jaar : 2017
Journal : Oncotarget
Volume : 8(34)
Pagina's : 56185-56198

Accuracy and precision assessment for activity quantification in individualized dosimetry of 177Lu-DOTATATE therapy.

Auteurs : Marin G, Vanderlinden B, Karfis I, Guiot T, Wimana Z, Flamen P, Vandenberghe S
Jaar : 2017
Journal : EJNMMI Phys
Volume : 4
Pagina's : 7

A multicentre comparison of quantitative (90)Y PET/CT for dosimetric purposes after radioembolization with resin microspheres : The QUEST Phantom Study.(103 collaborators : for Institut Bordet : B. Vanderlinden and P. Flamen)

Auteurs : Willowson KP, Tapner M, Bailey DL, + collaborators (among others :, Flamen P, Vanderlinden B
Jaar : 2015
Journal : Eur J Nucl Med Mol Imaging
Volume : 42
Pagina's : 1202-22

Radioembolisation and portal vein embolization before resection of large hepatocellular carcinoma.

Auteurs : Bouazza F, Poncelet A, Garcia CA, Delatte P, Engelholm JL, Gomez Galdon M, Deleporte A, Hendlisz A, Vanderlinden B, Flamen P, Donckier V
Jaar : 2015
Journal : World J Gastroenterol
Volume : 21
Pagina's : 9666-70

Mucolytic Agents Can Enhance HER2 Receptor Accessibility for [(89)Zr]Trastuzumab, Improving HER2 Imaging in a Mucin-Overexpressing Breast Cancer Xenograft Mouse Model.

Auteurs : Wimana Z, Gebhart G, Guiot T, Vanderlinden B, Morandini R, Doumont G, Sherer F, Van Simaeys G, Goldman S, Ghanem G, Flamen P
Jaar : 2015
Journal : Mol Imaging Biol
Volume : 17(5)
Pagina's : 697-703

Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab.

Auteurs : Muylle K, Flamen P, Vugts DJ, Guiot T, Ghanem G, Meuleman N, Bourgeois P, Vanderlinden B, van Dongen GA, Everaert H, Vaes M, Bron D
Jaar : 2015
Journal : Eur J Nucl Med Mol Imaging
Volume : 42(8)
Pagina's : 1304-14

Y90 radioembolization of colorectal cancer liver metastases: response assessment by contrast-enhanced computed tomography with or without PET-CT guidance.

Auteurs : Vouche M, Salem R, Miller FH, Lemort M, Vanderlinden B, De Becker D, Hendlisz A, Flamen P
Jaar : 2015
Journal : Clin Imaging
Volume : 39(3)
Pagina's : 454-62

Pretreatment Dosimetry in HCC Radioembolization with 90Y Glass Microspheres Cannot Be Invalidated with a Bare Visual Evaluation of 99mTc-MAA Uptake of Colorectal Metastases Treated with Resin Microspheres.

Auteurs : Chiesa C, Lambert B, Maccauro M, Ezziddin S, Ahmadzadehfar H, Dieudonné A, Cremonesi M, Konijnenberg M, Lassmann M, Pettinato C, Strigari L, Vanderlinden B, Crippa F, Flamen P, Garin E
Jaar : 2014
Journal : J. Nucl. Med.
Volume : 55(7)
Pagina's : 1215-16

Tumor Texture Analysis in 18F-FDG PET: Relationships Between Texture Parameters, Histogram Indices, Standardized Uptake Values, Metabolic Volumes, and Total Lesion Glycolysis.

Auteurs : Orlhac F, Soussan M, Maisonobe JA, Garcia C, Vanderlinden B, Buvat I
Jaar : 2014
Journal : J. Nucl. Med.
Volume : 55(3)
Pagina's : 414-22

Multicenter Harmonization of 89Zr PET/CT Performance.

Auteurs : Makris NE, Boellaard R, Visser EP, de Jong JR, Vanderlinden B, Wierts R, van der Veen BJ, Greuter HJ, Vugts DJ, van Dongen GA, Lammertsma AA, Huisman MC
Jaar : 2014
Journal : J. Nucl. Med.
Volume : 55(2)
Pagina's : 264-7

Reply to Letter re: General Theory of Predictive Dosimetry for Yttrium-90 Radioembolization to Sites Other Than the Liver.

Auteurs : Muylle K, Vanderlinden B
Jaar : 2014
Journal : Cardiovasc Intervent Radiol
Volume : 37(4)
Pagina's : 1118-19

Radioembolization of the Spleen: A Revisited Approach for the Treatment of Malignant Lymphomatous Splenomegaly. (epub online 2012)

Auteurs : Muylle K, Nguyen J, de Wind A, Meuleman N, Delatte P, Vanderlinden B, Roelandts M, Vanderstappen A, Bron D, Flamen P
Jaar : 2013
Journal : Cardiovasc Intervent Radiol
Volume : 36(4)
Pagina's : 1155-60

Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapy.

Auteurs : Maisonobe JA, Garcia C, Necib H, Vanderlinden B, Hendlisz A, Flamen P, Buvat I
Jaar : 2013
Journal : Eur J Nucl Med Mol Imaging
Volume : 40(2)
Pagina's : 166-74